Current Edition

$47M

Ligand Receives $47 Million from WuXi Biologics for Expansion of Worldwide OmniAb® Platform License Agreement

Updates 2018 Full Year and Second Quarter Financial Guidance Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces it has received $47 million as a result of signing …

Continue Reading →
expansion

PCI’s Tredegar Site Announces Significant Expansion of Analytical Laboratories at its Center of Excellence for Contained Manufacturing

Global pharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce a laboratory expansion at its site in Tredegar, Wales, UK. The Tredegar …

Continue Reading →
expansion

Recipharm completes Blow-fill-seal expansion at Kaysersberg facility

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at its facility …

Continue Reading →
cancer

Phillips-Medisize Announces Expansion of Significant Medical Customer for Molex Little Rock Facility

Phillips-Medisize, a Molex company, announces the expansion of a significant medical customer for the Molex Little Rock facility. The long-time customer is a leader in …

Continue Reading →
clinical

Almac Group announces further expansion in support of clinical and commercial drug supplies at its European Campus in Dundalk, Ireland following successful HPRA Inspections

Almac Group, the global contract pharmaceutical development and manufacturing organisation, today confirmed the successful completion of Health Products Regulatory Authority (HPRA) inspections of Almac Clinical …

Continue Reading →